S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
about
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
description
clinical trial
@en
klinisch onderzoek
@nl
name
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
@en
type
label
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
@en
prefLabel
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
@en
P1050
P6153
P1476
A Phase II Study of Isatuximab ...... viously Treated AL Amyloidosis
@en
P3098
NCT03499808
P580
2018-03-08T00:00:00Z
P582
2021-10-30T00:00:00Z